Atossa Genetics Inc Stock
Price
Target price
€1.60
€1.60
-0.740%
-0.012
-0.740%
€3.72
14:11 / Tradegate
WKN: A2JJ99 / Symbol: ATOS / Name: Atossa Genetics / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Atossa Genetics Inc Stock
Atossa Genetics Inc shows a slight decrease today, losing -€0.012 (-0.740%) compared to yesterday.
Our community is currently high on Atossa Genetics Inc with 4 Buy predictions and 1 Sell predictions.
As a result the target price of 3 € shows a very positive potential of 87.27% compared to the current price of 1.6 € for Atossa Genetics Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Atossa Genetics Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Atossa Genetics Inc in the next few years
Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atossa Genetics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atossa Genetics Inc | -0.740% | 0.373% | 39.378% | 142.161% | 71.520% | 11.928% | -56.891% |
| InVivo Therapeutics Holdings | 6.450% | 55.779% | 50.121% | -64.692% | -54.942% | -99.934% | -99.970% |
| Star Equity Holdings Inc. | -1.200% | 0.000% | 0.602% | 14.384% | -11.170% | -68.371% | -85.653% |
| NetScientific plc | -0.770% | -7.143% | -13.333% | -15.584% | 6.557% | -9.091% | -47.581% |
Comments
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $4.00 price target on the stock.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for ATOS provided by MarketBeat
